The purpose of this research is to develop a database of patients undergoing minimally invasive procedures for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The minimally invasive procedures to be included in this database are Urolift and Rezum treatments. Men who undergo the Urolift and Rezum treatments in our office will be given questionnaires at 1, 3, 6, 12, and 18 months post-treatment to assess quality of life related to their BPH treatment procedure. These questionnaires include the International Prostate Symptom Score (IPSS) and International Index of Erectile Function (IIEF). The minimally invasive treatment for BPH database will also record demographic information, PSA levels, ultrasound/post-void residual results and prior interventions of patients participating in this study.
For more information, please contact our research coordinator at 516-535-4184 or email@example.com